Zhen Yu

2.8k citations
104 papers · 1.5k indexed · h-index 24
Topics
Chronic Lymphocytic Leukemia Research (14 papers)Multiple Myeloma Research and Treatments (12 papers)Lymphoma Diagnosis and Treatment (10 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood

In The Last Decade

Zhen Yu

97 papers receiving 1.5k citations

Peers

Zhen Yu
Comparison fields: 5 of 130
  • Molecular Biology 456
  • Immunology 230
  • Health, Toxicology and Mutagenesis 201
  • Epidemiology 177
  • Oncology 169
Replace Ke Huang with:
Ke Huang China
Huai‐Dong Song China
Hong Sun United States
Renata Kozyraki France
Liping Xia China
Kiyofumi Saijoh Japan
Catherine Massart France
Dan Liang China
Xia Sheng China
Andong Qiu United States
Zhen Yu relative to Ke Huang China Ke Huang's profile →
Citations per field
00.5×1.5×
Ke Huang · 1×
Citations per year

Countries citing papers authored by Zhen Yu

Since Specialization
Citations

This map shows the geographic impact of Zhen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Yu more than expected).

Fields of papers citing papers by Zhen Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Yu. The network helps show where Zhen Yu may publish in the future.

Co-authorship network of co-authors of Zhen Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen Yu. A scholar is included among the top collaborators of Zhen Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen Yu. Zhen Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 4
3 18
4 5
5 2
6 10
7 1
8 8
9 17
10 10
11 5
12 38
13 13
14 50
15 2
16 11
17 39
18 35
19 42
20
EFFECT OF SELENIUM ON PROTEIN P16 EXPRESSION IN THE TESTICLE SPERMATOGONIUM OF RAT WITH COLON CANCER INDUCED BY AZOXYMETHANE
1

About Zhen Yu

Zhen Yu is a scholar working on Genetics, Hematology and Immunology, having authored 104 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (14 papers), Multiple Myeloma Research and Treatments (12 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Genetics (159 citations), Health, Toxicology and Mutagenesis (201 citations) and Hematology (137 citations). Zhen Yu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Lin Fu, Yuan‐Hua Chen, Fangbiao Tao, Jiahu Hao, Hua Wang, Yong-Fang Hu, Taibo Liu, Dongyu Jia, Puyu Su and Huihui Ding. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026